Indications and uses
To help restore mental alertness when experiencing fatigue.
To help restore mental alertness when experiencing fatigue.
At first sign of symptoms: Adults and children 12 years and older: 1 tablet every ½ to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours. Children 4 to 11 years: 1 tablet every ½ to hour until symptoms lessen, then continue with standard dosage. Do not exceed 8 tablets in 24 hours. For children under 4 years, consult your health professional. Standard Dosage: Ad...
To help restore mental alertness when experiencing fatigue.
*Apis mellifica 6X, Calcarea phosphorica 12X, *Dulcamara 6X, *Equisetum hyemale 4X, Ferrum iodatum 12X, *Fumaria officinalis 4X, *Gentiana lutea 5X, *Geranium robertianum 4X, Kali iodatum 8X, *Nasturtium aquaticum 4X, Natrum sulphuricum 3X, *Pinus sylvestris 4X, *Sarsaparilla 6X,*Scrophularia nodosa 3X, *Sticta pulmonaria 5X, *Teurcium scorodonia 3X, *Veronica officinalis 3X.
*Natural Ingredients.
Lactose, Magnesium stearate.
Alertness Aid
At first sign of symptoms: Adults and children 12 years and older: 1 tablet every ½ to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours. Children 4 to 11 years: 1 tablet every ½ to hour until symptoms lessen, then continue with standard dosage. Do not exceed 8 tablets in 24 hours.
For children under 4 years, consult your health professional.
Standard Dosage: Adults and children 12 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours.
Children 4 to 11 years: 2 tablets per day, taking 1 tablet every 6 to 8 hours.
For children under 4 years, consult your health professional.
Allow tablets to dissolve completely in the mouth, do not swallow.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. For occasional use only. Not a substitute for sleep. If symptoms persist or worsen, a health professional should be consulted. Do not use if known hypersensitivity to BodyAnewTM Fatigue or any of its ingredients exists.
Keep out of reach of children.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 62795-1032-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-2d2b-f424-e053-dadaa90a57ce | BodyAnew Fatigue HCP Tablet |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62795-1032-2 | BodyAnew Fatigue HCP | 100 in 1 BOTTLE | TABLET | 100 | 1 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 62795-1032 | BODYANEW FATIGUE HCP (APIS MELLIFERA, TRIBASIC CALCIUM PHOSPHATE, SOLANUM DULCAMARA TOP, EQUISETUM HYEMALE, FERROUS IODIDE, FUMARIA OFFICINALIS FLOWERING TOP, GENTIANA LUTEA ROOT, GERANIUM ROBERTIANUM, NASTURTIUM OFFICINALE, SODIUM SULFATE,PINUS SYLVESTRIS LEAFY TWIG, SMILAX REGELII ROOT, SCROPHULARIA NODOSA, LOBARIA PULMONARIA, TEUCRIUM SCORODONIA FLOWERING TOP, AND TEUCRIUM SCORODONIA FLOWERING TOP) TABLET [MEDINATURA INC] | 1 | Legacy NDC, 1 package rows | 20150310_2e289c15-23b8-4195-8887-f87c4e12e02f.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 62795-1032-2 | EA - Each | 62795-1032 | c94bf22e-6bbd-4d55-8ee9-3ed3ae162777 | 1 | 2015-10-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| EQUISETUM HYEMALE | ACTIVE INGREDIENT | 59677RXH25 | 1 | |
| FERROUS IODIDE | ACTIVE INGREDIENT | F5452U54PN | 1 | |
| FUMARIA OFFICINALIS FLOWERING TOP | ACTIVE INGREDIENT | VH659J61ZL | 1 | |
| GENTIANA LUTEA ROOT | ACTIVE INGREDIENT | S72O3284MS | 1 | |
| GERANIUM ROBERTIANUM | ACTIVE INGREDIENT | R5I1HK0UBL | 1 | |
| LOBARIA PULMONARIA | ACTIVE INGREDIENT | D1YM0P5Z2T | 1 | |
| NASTURTIUM OFFICINALE | ACTIVE INGREDIENT | YH89GMV676 | 1 | |
| PINUS SYLVESTRIS LEAFY TWIG | ACTIVE INGREDIENT | Q1RGP4UB73 | 1 | |
| POTASSIUM IODIDE | ACTIVE INGREDIENT | 1C4QK22F9J | 1 | |
| SCROPHULARIA NODOSA | ACTIVE INGREDIENT | 7H443NUB2T | 1 | |
| SMILAX REGELII ROOT | ACTIVE INGREDIENT | 2H1576D5WG | 1 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 1 | |
| SOLANUM DULCAMARA TOP | ACTIVE INGREDIENT | KPS1B1162N | 1 | |
| TEUCRIUM SCORODONIA FLOWERING TOP | ACTIVE INGREDIENT | LOK3I16O7G | 1 | |
| TRIBASIC CALCIUM PHOSPHATE | ACTIVE INGREDIENT | 91D9GV0Z28 | 1 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| CALCIUM CATION | ACTIVE MOIETY | 2M83C4R6ZB | 1 | |
| EQUISETUM HYEMALE | ACTIVE MOIETY | 59677RXH25 | 1 | |
| FERROUS IODIDE | ACTIVE MOIETY | F5452U54PN | 1 | |
| FUMARIA OFFICINALIS FLOWERING TOP | ACTIVE MOIETY | VH659J61ZL | 1 | |
| GENTIANA LUTEA ROOT | ACTIVE MOIETY | S72O3284MS | 1 | |
| GERANIUM ROBERTIANUM | ACTIVE MOIETY | R5I1HK0UBL | 1 | |
| IODIDE ION | ACTIVE MOIETY | 09G4I6V86Q | 1 | |
| LOBARIA PULMONARIA | ACTIVE MOIETY | D1YM0P5Z2T | 1 | |
| NASTURTIUM AQUATICUM | ACTIVE MOIETY | YH89GMV676 | 1 | |
| PINUS SYLVESTRIS LEAFY TWIG | ACTIVE MOIETY | Q1RGP4UB73 | 1 | |
| SARSAPARILLA | ACTIVE MOIETY | 2H1576D5WG | 1 | |
| SCROPHULARIA NODOSA | ACTIVE MOIETY | 7H443NUB2T | 1 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 1 | |
| SOLANUM DULCAMARA TOP | ACTIVE MOIETY | KPS1B1162N | 1 | |
| TEUCRIUM SCORODONIA FLOWERING TOP | ACTIVE MOIETY | LOK3I16O7G | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 62795-1032 | 62795-1032-2 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, DELAYED RELEASE / ORAL | 160 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 620 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, DELAYED RELEASE / ORAL | 144 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, COATED / ORAL | 332.05 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE, FOR SUSPENSION / ORAL | 14 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, SOLUTION / INTRAVENOUS | 0.45 %w/v | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / INTRAVITREAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, DELAYED RELEASE / ORAL | 231.84 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, DELAYED RELEASE / ORAL | 1060 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / RESPIRATORY (INHALATION) | 0.13 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, FILM COATED / ORAL | 590 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, SUGAR COATED / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / VAGINAL | 430 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CREAM / VAGINAL | 3 %w/w | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 47 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 984e1bfa-732a-4fd6-af74-11daf34b0b12 | 2e289c15-23b8-4195-8887-f87c4e12e02f | 2015-03-09 | Warnings | 984e1bfa-732a-4fd6-af74-11daf34b0b12 2e289c15-23b8-4195-8887-f87c4e12e02f |
Adverse event summaries are temporarily unavailable. Other product information remains available.